A Chat with Todd Perman: Mission-Driven CEO Leading Preventive Healthcare Innovation at Seed Healthcare

This week, Stephen Ibaraki has an exclusive interview with Todd Perman.

As CEO and General Partner of Seed Healthcare, Todd is applying his 30+ years of healthcare experience, investment knowledge and growth strategies to helping companies disrupt healthcare in the U.S. and abroad.

Todd's unique combination of clinical insight and financial expertise, honed through his career as an investment banker and over a decade in medical devices at Stryker Corporation, led him to launch Seed Healthcare in 2020, which guides various stakeholders in healthcare companies through capital strategies, the integration of emerging technologies, and complex clinical revenue enhancement.

Todd launched the Seed Healthcare Fund, a $100 million fund dedicated to supporting disruptive healthcare technologies poised to drive change in healthcare. The key theory of change is to revolutionize healthcare through early disease detection. By investing in cutting-edge diagnostics and processes, the goal is to improve survival rates, reduce costs, and enhance patient outcomes, driving a significant shift in the healthcare paradigm. Key differentiators for the Fund include the expert Advisory Board, impact investment fund designation, and network effect of a healthcare-focused venture firm.